gdc
Submit Your Art
Subscribe

ASCO 2021

Can Immunotherapy Be a Cure in Advanced Bladder or Kidney Cancer?
ASCO 2021Bladder Cancer
Can Immunotherapy Be a Cure in Advanced Bladder or Kidney Cancer?
By Meg Barbor, MPH
Web Exclusives
Adding Tukysa to the Treatment Regimen Extends Survival in Patients with HER2-Positive Metastatic Breast Cancer
ASCO 2021Breast Cancer
Adding Tukysa to the Treatment Regimen Extends Survival in Patients with HER2-Positive Metastatic Breast Cancer
By Chase Doyle
Web Exclusives
Tecentriq Slashes Risk of Cancer Progression, Death in Patients with Early-Stage Non–Small-Cell Lung Cancer and PD-L1 Expression
Lung CancerASCO 2021
Tecentriq Slashes Risk of Cancer Progression, Death in Patients with Early-Stage Non–Small-Cell Lung Cancer and PD-L1 Expression
By Phoebe Starr
ASCO 2021 Highlights
Bavencio Leads to Long-Term Survival in Patients with Metastatic Merkel-Cell Carcinoma
Skin CancerASCO 2021
Bavencio Leads to Long-Term Survival in Patients with Metastatic Merkel-Cell Carcinoma
By Chase Doyle
ASCO 2021 Highlights
Libtayo Safe and Effective in Immunocompromised Patients with Advanced Skin Cancer
Skin CancerASCO 2021
Libtayo Safe and Effective in Immunocompromised Patients with Advanced Skin Cancer
By Chase Doyle
ASCO 2021 Highlights
¹⁷⁷Lu-PSMA-617, Novel Targeted Therapy, Extends Survival in Men with Metastatic Prostate Cancer
Prostate CancerASCO 2021Targeted Therapies
¹⁷⁷Lu-PSMA-617, Novel Targeted Therapy, Extends Survival in Men with Metastatic Prostate Cancer
By Phoebe Starr
ASCO 2021 Highlights
Increasing PSA Screening in Black Men Will Improve the Diagnosis of Prostate Cancer and Reduce Deaths
Prostate CancerASCO 2021
Increasing PSA Screening in Black Men Will Improve the Diagnosis of Prostate Cancer and Reduce Deaths
By Chase Doyle
ASCO 2021 Highlights
Challenges and Progress in the Treatment of Patients with High-Risk, Relapsed Multiple Myeloma
Multiple MyelomaASCO 2021
Challenges and Progress in the Treatment of Patients with High-Risk, Relapsed Multiple Myeloma
By Meg Barbor, MPH
ASCO 2021 Highlights
Patient-Reported Outcomes and Vision-Related Symptoms Can Guide the Dosing of Blenrep in Patients with Relapsed or Refractory Multiple Myeloma
Multiple MyelomaASCO 2021
Patient-Reported Outcomes and Vision-Related Symptoms Can Guide the Dosing of Blenrep in Patients with Relapsed or Refractory Multiple Myeloma
By Chase Doyle
ASCO 2021 Highlights
New Approaches to Systemic Therapy for Patients with Stage III Melanoma
MelanomaASCO 2021
New Approaches to Systemic Therapy for Patients with Stage III Melanoma
By Chase Doyle
ASCO 2021 Highlights
  • 1
  • 2
Page 1 of 2
Results 1 - 10 of 20

Subscribe to CONQUER™: the patient voice™

Receive timely cancer news & updates, patient stories, and more.

Country
Race or Ethnicity
Gender
Profession or Role
Primary Interest
Other Interests